|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shaukat A, Mongin SJ, Geisser MS, Lederle
FA, Bond JH, Mandel JS and Church TR: Long-term mortality after
screening for colorectal cancer. N Engl J Med. 369:1106–1114. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Migliore L, Igheli F, Spisni R and Coppede
F: Genetics, Cytogenetics, and epigenetics of colorectal cancer. J
Biomed Biotech. 2011:7923622011. View Article : Google Scholar
|
|
5
|
Grady WM and Ulrich CM: DNA alkylation and
DNA methylation: Cooperating mechanisms driving the formation of
colorectal adenomas and adenocarcinomas? Gut. 56:318–320. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inbar-Feigenberg M, Choufani S, Butcher
DT, Roifman M and Weksberg R: Basic concepts of epigenetics. Fertil
Steril. 99:607–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Epigenetic gene silencing in
cancer: The DNA hypermethylome. Hum Mol Genet 16 Spec No.
1:R50–R59. 2007. View Article : Google Scholar
|
|
8
|
Fakhr Ghavifekr M, Hagh Farshdousti M,
Shanehbandi D and Baradaran B: DNA methylation pattern as important
epigenetic criterion in cancer. Genet Res Int.
2013:3175692013.PubMed/NCBI
|
|
9
|
Jaenisch R and Bird A: Epigenetic
regulation of gene expression: How the genome integrates intrinsic
and environmental signals. Nat Genet. 33 Suppl:S245–S254. 2003.
View Article : Google Scholar
|
|
10
|
Carmona FJ, Azuara D, Berenguer-Llergo A,
Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R,
Villanueva A, Fraga MF, et al: DNA methylation biomarkers for
noninvasive diagnosis of colorectal cancer. Cancer Prev Res
(Phila). 6:656–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahn JB, Chung WB, Maeda O, Shin SJ, Kim
HS, Chung HC, Kim NK and Issa JP: DNA methylation predicts
recurrence from resected stage III proximal colon cancer. Cancer.
117:1847–1854. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang JC, Kim S, Helmke BP, Yu WW, Du KL,
Lu MM, Strobeck M, Yu Q and Parmacek MS: Analysis of
SM22alpha-deficient mice reveals unanticipated insights into smooth
muscle cell differentiation and function. Mol Cell Biol.
21:1336–1344. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Assinder SJ, Stanton JA and Prasad PD:
Transgelin: An actin-binding protein and tumour suppressor. Int J
Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lawson D, Harrison M and Shapland C:
Fibroblast transgelin and smooth muscle SM22alpha are the same
protein, the expression of which is down-regulated in many cell
lines. Cell Motil Cytoskeleton. 38:250–257. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shields JM, Rogers-Graham K and Der CJ:
Loss of transgelin in breast and colon tumors and in RIE-1 cells by
Ras deregulation of gene expression through Raf-independent
pathways. J Biol Chem. 277:9790–9799. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Albiges-Rizo C, Destaing O, Fourcade B,
Planus E and Block MR: Actin machinery and mechanosensitivity in
invadopodia, podosomes and focal adhesions. J Cell Sci.
122:3037–3049. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li LS and Kim H, Rhee H, Kim SH, Shin DH,
Chung KY, Park KS, Paik YK, Chang J and Kim H: Proteomic analysis
distinguishes basaloid carcinoma as a distinct subtype of nonsmall
cell lung carcinoma. Proteomics. 4:3394–3400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Prasad PD, Stanton JA and Assinder SJ:
Expression of the actin-associated protein transgelin (SM22) is
decreased in prostate cancer. Cell Tissue Res. 339:337–347. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Klade CS, Voss T, Krystek E, Ahorn H,
Zatloukal K, Pummer K and Adolf GR: Identification of tumor
antigens in renal cell carcinoma by serological proteome analysis.
Proteomics. 1:890–898. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sayar N, Karahan G, Konu O, Bozkurt B,
Bozdogan O and Yulug IG: Transgelin gene is frequently
downregulated by promoter DNA hypermethylation in breast cancer.
Clin Epigenetics. 7:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang ZW, Yang ZM, Zheng YC and Chen ZD:
Transgelin induces apoptosis of human prostate LNCaP cells through
its interaction with p53. Asian J Androl. 12:186–195. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nair RR, Solway J and Boyd DD: Expression
cloning identifies transgelin (SM22) as a novel repressor of 92-kDa
type IV collagenase (MMP-9) expression. J Biol Chem.
281:26424–26436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie XL, Liu YB, Liu YP, Du BL, Li Y, Han M
and Li BH: Reduced expression of SM22 is correlated with low
autophagy activity in human colorectal cancer. Pathol Res Pract.
209:237–243. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gimona M, Kaverina I, Resch GP, Vignal E
and Burgstaller G: Calponin repeats regulate actin filament
stability and formation of podosomes in smooth muscle cells. Mol
Biol Cell. 14:2482–2491. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han M, Dong LH, Zheng B, Shi JH, Wen JK
and Cheng Y: Smooth muscle 22 alpha maintains the differentiated
phenotype of vascular smooth muscle cells by inducing filamentous
actin bundling. Life Sci. 84:394–401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Q, Shi R, Wang Y and Niu X: TAGLN
suppresses proliferation and invasion, and induces apoptosis of
colorectal carcinoma cells. Tumour Biol. 34:505–513. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu L, Gao Y, Chen Y, Xiao Y, He Q, Qiu H
and Ge W: Quantitative proteomics reveals that distant
recurrence-associated protein R-Ras and Transgelin predict
post-surgical survival in patients with Stage III colorectal
cancer. Oncotarget. 7:43868–43893. 2016.PubMed/NCBI
|
|
28
|
Yu B, Chen X, Li J, Qu Y, Su L, Peng Y,
Huang J, Yan J, Yu Y, Gu Q, et al: Stromal fibroblasts in the
microenvironment of gastric carcinomas promote tumor metastasis via
upregulating TAGLN expression. BMC Cell Biol. 14:172013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen JY, Xu L, Fang WM, Han JY, Wang K and
Zhu KS: Identification of PA28β as a potential novel biomarker in
human esophageal squamous cell carcinoma. Tumour Biol.
39:10104283177197802017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao L, Wang H, Deng YJ, Wang S, Liu C,
Jin H and Ding YQ: Transgelin as a suppressor is associated with
poor prognosis in colorectal carcinoma patients. Mod Pathol.
22:786–796. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yeo M, Park HJ, Kim DK, Kim YB, Cheong JY,
Lee KJ and Cho SW: Loss of SM22 is a characteristic signature of
colon carcinogenesis and its restoration suppresses colon
tumorigenicity in vivo and in vitro. Cancer. 116:2581–2589.
2010.PubMed/NCBI
|
|
32
|
Zhou HM, Fang YY, Weinberger PM, Ding LL,
Cowell JK, Hudson FZ, Ren M, Lee JR, Chen QK, Su H, et al:
Transgelin increases metastatic potential of colorectal cancer
cells in vivo and alters expression of genes involved in cell
Motility. BMC Cancer. 16:552016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin Y, Buckhaults PJ, Lee JR, Xiong H,
Farrell C, Podolsky RH, Schade RR and Dynan WS: Association of the
actin-binding protein transgelin with lymph node metastasis in
human colorectal cancer. Neoplasia. 11:864–873. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prinjha RK, Shapland CE, Hsuan JJ, Totty
NF, Mason IJ and Lawson D: Cloning and sequencing of cDNAs encoding
the actin cross-linking protein transgelin defines a new family of
actin-associated proteins. Cell Motil Cytoskeleton. 28:243–255.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamamura H, Masuda H, Ikeda W, Tokuyama T,
Takagi M, Shibata N, Tatsuta M and Takahashi K: Structure and
expression of the human SM22alpha gene, assignment of the gene to
chromosome 11, and repression of the promoter activity by cytosine
DNA methylation. J Biochem. 122:157–167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mohn F, Weber M, Rebhan M, Roloff TC,
Richter J, Stadler MB, Bibel M and Schübeler D: Lineage-specific
polycomb targets and de novo DNA methylation define restriction and
potential of neuronal progenitors. Mol Cell. 30:755–766. 2008.
View Article : Google Scholar : PubMed/NCBI
|
